Survivorship after adolescent and young adult cancer: models of care, disparities, and opportunities
JNCI: Journal of the National Cancer Institute · 01.09.2024 · 116 (9) · 1417-1428
DOI: 10.1093/jnci/djae119 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, online erschienen am 04.06.2024. Verfasst von Amy M Berkman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, USA. Hauptthemen laut MEDLINE: Cancer Survivors, Neoplasms, Survivorship, Healthcare Disparities. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCI NIH HHS, Archer Foundation.
Abstract (Originalsprache)
Survivors of adolescent and young adult (AYA; age 15-39 years at diagnosis) cancer are a growing population with the potential to live for many decades after treatment completion. Survivors of AYA cancer are at risk for adverse long-term outcomes including chronic conditions, secondary cancers, impaired fertility, poor psychosocial health and health behaviors, and financial toxicity. Furthermore, survivors of AYA cancer from racially minoritized and low socioeconomic status populations experience disparities in these outcomes, including lower long-term survival. Despite these known risks, most survivors of AYA cancer do not receive routine survivorship follow-up care, and research on delivering high-quality, evidence-based survivorship care to these patients is lacking. The need for survivorship care was initially advanced in 2006 by the Institute of Medicine. In 2019, the Quality of Cancer Survivorship Care Framework (QCSCF) was developed to provide an evidence-based framework to define key components of optimal survivorship care. In this commentary focused on survivors of AYA cancer, we apply the QCSCF framework to describe models of care that can be adapted for their unique needs, multilevel factors limiting equitable access to care, and opportunities to address these factors to improve short- and long-term outcomes in this vulnerable population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, USA.
- Department of Health Promotion and Behavioral Sciences, University of Texas Health Science Center at Houston, School of Public Health, Dallas, TX, USA.
- School of Nursing, Columbia University Irving Medical Center, New York, NY, USA.
- Department of Medicine and Pediatrics, Tufts University School of Medicine, Boston, MA, USA.
- Institute for Clinical Research and Health Policy Studies and Division of Hematology/Oncology, Tufts Medical Center, Boston, MA, USA.
- Departments of Pediatrics, Medicine, and Population & Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
ORCID-Profile: Amy M Berkman, Michael E Roth
Förderung
- NIH HHS
- NCI NIH HHS
- Archer Foundation
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Berkman, A. M., Betts, A. C., Beauchemin, M., Parsons, S. K., Freyer, D. R., & Roth, M. E. (2024). Survivorship after adolescent and young adult cancer: models of care, disparities, and opportunities. JNCI: Journal of the National Cancer Institute, 116(9), 1417-1428. https://doi.org/10.1093/jnci/djae119
Vancouver
Berkman AM, Betts AC, Beauchemin M, Parsons SK, Freyer DR, Roth ME. Survivorship after adolescent and young adult cancer: models of care, disparities, and opportunities. JNCI: Journal of the National Cancer Institute. 2024;116(9):1417-1428. doi:10.1093/jnci/djae119
BibTeX
@article{Berkman2024,
author = {Berkman, Amy M and Betts, Andrea C and Beauchemin, Melissa and Parsons, Susan K and Freyer, David R and Roth, Michael E},
title = {Survivorship after adolescent and young adult cancer: models of care, disparities, and opportunities},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2024},
volume = {116},
number = {9},
pages = {1417--1428},
doi = {10.1093/jnci/djae119}
}
EUVIMED